The counter broke up from 2 months resistance ~ 0.26 on last trading day Buying volume was significant. Shall buying interest maintain, next target price shall be 0.3 Current price is still below its IPO debut price on end of 2017 and ~ 70% discount from its peak. The downtrend since last April has paused for the moment.
Relevant News:
[1]
https://www.theedgesingapore.com/clearbridge-health-rides-chinas-biotech-boom-cancer-diagnostic-spinoff
[2]
http://infopub.sgx.com/FileOpen/Clearbridge%20Health_Corporate%20Presentation%20Q2%20and%206M%20FY2018.ashx?App=Announcement&FileID=521612
No comments:
Post a Comment